Glycopeptide antibiotic drug stability in aqueous solution

Area of Science:

• Pharmaceutical Sciences
• Microbiology
• Drug Delivery

Background:

• Glycopeptide antimicrobials are vital for treating Gram-positive bacterial infections.
• Current lyophilized formulations present economic and practical challenges.
• Liquid formulations offer significant advantages for drug accessibility and administration.

Purpose of the Study:

• To review recent advancements in stabilizing glycopeptide antibiotics in aqueous solutions.
• To identify key degradation pathways and strategies for mitigation.
• To assess the market availability and stability of existing glycopeptide drugs.

Main Methods:

• Literature review of published studies and patents on glycopeptide stability.
• Analysis of chemical and physical degradation mechanisms.
• Evaluation of formulation strategies including pH control, excipients, and solvent minimization.

Main Results:

• Chemical degradation is influenced by pH, oxygen, and solvent exposure.
• Physical degradation can be reduced by excipients like sugars, amino acids, polyols, and surfactants.
• Several glycopeptide antibiotics show potential for stable aqueous formulations.

Conclusions:

• Understanding degradation mechanisms is key to developing stable liquid glycopeptide formulations.
• Stable aqueous formulations can improve treatment options for multidrug-resistant pathogens.
• This advancement is critical for regions lacking cold-chain infrastructure.